Skip to main content
Home / Current Cancer Therapy Reviews, Volume 2, Number 2
Current Cancer Therapy Reviews publishes frontier reviews on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal's aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in cancer therapy.

Publisher: Bentham Science Publishers

More about this publication?
Volume 2, Number 2, 2006

Articles

Human T-Cell Leukemia Virus Type 1: Transition from Latent Infection to Pathogenic Progression and Implications for Molecular Therapy
pp. 101-113(13)
Authors: Tabakin-Fix, Yulia; Azran-Shaish, Inbal; Schavinsky-Khrapunsky, Yana; Chamias, Rachel; Gohari, Lilach; Huleihel, Mahmoud; Li-Weber, Min; Aboud, Mordechai

Favourites:
ADD

Role of NF-κB and NF-κB-regulated Gene Products in Chemoresistance and Radioresistance
pp. 115-125(11)
Authors: Sethi, Gautam; Aggarwal, Bharat B.

Favourites:
ADD

Epigenetic Therapies of Cancer
pp. 127-135(9)
Authors: Bootwala, Yasmin; Bandyopadhyay, Debdutta

Favourites:
ADD

Genetic Polymorphisms of Drug Metabolising Enzymes and Drug Transporters in Relation to Cancer Risk
pp. 137-155(19)
Authors: Bosch, Tessa M.; Meijerman, Irma; Beijnen, Jos H.; Schellens, Jan H.M.

Favourites:
ADD

The Insulin-Like Growth Factor (IGF) Signaling Pathway: Strategies for Successful Therapeutic Tasks in Cancer Treatment
pp. 157-167(11)
Authors: Breuhahn, Kai; Nussbaum, Tanja; Singer, Stephan; Schirmacher, Peter

Favourites:
ADD

Treatment Strategies for Multiple Myeloma in the Age of Novel Therapies
pp. 169-183(15)
Authors: Catley, Laurence; Anderson, Kenneth C.

Favourites:
ADD

Mechanism of Action and Therapeutic Potential of Novel Adamantyl Retinoid-Related Molecules
pp. 185-198(14)
Authors: Piedrafita, F. J.; Ortiz, Maria A.

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content